Sweden · Delayed Price · Currency is SEK Freemelt Holding AB Earnings Call Transcripts
Fiscal Year 2026
-
Revenue more than doubled year-over-year in Q1, driven by strong operational progress and strategic customer projects. Gross margin reached 57% due to a favorable sales mix, and the company remains focused on scaling through a hybrid business model and expanding in fusion and defense sectors.
Fiscal Year 2025
-
Record 2025 sales grew 172% year-over-year, driven by strong machine demand and strategic partnerships. Outsourcing production and new financing improved scalability and reduced risk, while the company is well-positioned for growth in medtech, defense, and energy sectors.
-
Q3 delivered record order intake and sales, with a 228% year-to-date order growth and 128% net sales increase. Strategic expansion into China and outsourcing to Scanfil support future growth, while margins are expected to improve as production efficiencies rise.
-
Record order intake and invoicing in 2025 reflect strong demand across defense, energy, and medtech, with strategic expansion into China and breakthroughs in fusion energy applications. Modular design and supply chain agility support growth, while financial stability is maintained.
-
Q2 2025 saw record sales of SEK 19 million, matching the prior full year, with strong order intake and strategic milestones including entry into China and outsourcing manufacturing. Growth in defense, energy, and MedTech sectors, alongside a rising installed base, positions the company for continued expansion.
-
Q1 2025 saw record order book growth, driven by strong demand in defense and energy, despite no machine deliveries and negative operating cash flow. A successful rights issue raised SEK 90 million, and new strategic projects in fusion energy and defense were secured.
Fiscal Year 2024
-
Q4 saw strong growth in paid customer projects, strategic agreements in medtech and defense, and a solid order book. Rights issue raised SEK 90 million to support scaling, with continued momentum expected in defense, energy, and medtech amid favorable market trends.
-
A modular 3D printing company is shifting from research to industrial markets, focusing on defense, energy, and med tech with unique capabilities in copper, tungsten, and titanium. Industrial engagements are rising, with major growth expected by 2030.
-
Q3 saw strong machine sales growth, a major industrial breakthrough with the first eMELT installation, and a surge in paid feasibility studies, especially in defense, energy, and medtech. The order book grew to SEK 12 million, and the company expects continued momentum in 2025.
-
Q2 2024 featured strong commercial and technical progress, highlighted by the first eMELT industrial machine installation and growing demand in defense and energy sectors. Net sales were SEK 2.4 million, with a SEK 9.5 million order book and a SEK 52 million rights issue boosting cash reserves.